Biggest study yet backs Glaxo cervical cancer shot
Source: Reuters 06.27.2007
GlaxoSmithKline Plc's experimental vaccine Cervarix has proved more than 90 percent effective in preventing precancerous lesions due to two types of a virus responsible for most cases of cervical cancer.
